International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels - Wikidata - wikimedia - TriplyDB

International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels

International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels

http://www.wikidata.org/entity/Q28289168

about

A nomenclature for ligand-gated ion channels An amino acid outside the pore region influences apamin sensitivity in small conductance Ca2+-activated K+ channels Molecular targets for antiepileptic drug development Alterations in reversible protein histidine phosphorylation as intracellular signals in cardiovascular disease Oxidative Stress and Maxi Calcium-Activated Potassium (BK) Channels Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls Obstructing toxin pathways by targeted pore blockage Function and regulation of large conductance Ca(2+)-activated K+ channel in vascular smooth muscle cells The opportunities and challenges of large-scale molecular approaches to songbird neurobiology.Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3 Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor Genomics analysis of potassium channel genes in songbirds reveals molecular specializations of brain circuits for the maintenance and production of learned vocalizations.Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1)Small-Conductance Ca2+-Activated Potassium Channels Negatively Regulate Aldosterone Secretion in Human Adrenocortical Cells.K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy.The Concise Guide to PHARMACOLOGY 2013/14: ion channels Kalium: a database of potassium channel toxins from scorpion venom.Kv3-like potassium channels are required for sustained high-frequency firing in basal ganglia output neurons.De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.Disruption of the aortic elastic lamina and medial calcification share genetic determinants in mice.Ion Channels of Pituitary Gonadotrophs and Their Roles in Signaling and Secretion Differential molecular information of maurotoxin peptide recognizing IK(Ca) and Kv1.2 channels explored by computational simulation.Effects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladder Two distinct pools of large-conductance calcium-activated potassium channels in the somatic plasma membrane of central principal neurons The activation effect of hainantoxin-I, a peptide toxin from the Chinese spider, Ornithoctonus hainana, on intermediate-conductance Ca2+-activated K+ channels.New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.Calcium-activated potassium current modulates ventricular repolarization in chronic heart failure.Spider-venom peptides as bioinsecticides 11,12-EET stimulates the association of BK channel α and β(1) subunits in mitochondria to induce pulmonary vasoconstriction.Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels Ion channel pharmacology.Synaptic NMDA receptor-dependent Ca²⁺ entry drives membrane potential and Ca²⁺ oscillations in spinal ventral horn neurons.A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents.Intermediate conductance Ca2+-activated K+ channels modulate human placental trophoblast syncytialization High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.Modulation of K(Ca)3.1 channels by eicosanoids, omega-3 fatty acids, and molecular determinants

P2860

Q24609005-5455F5D4-F473-43DD-AB41-9FF6AADBDC67 Q24669897-EBF749A8-4660-4610-9CD1-6610BEAAF3DC Q24683346-575517E5-AFA0-48B9-8C39-933FADEF1412 Q26782883-B1C1D55E-5FDC-4B69-B390-D0BA4852CC93 Q26796569-2C83EDA6-3C5D-4559-9705-2ACD7606ED3C Q26798018-85A2710A-82EC-4176-9BA5-CC90B1DA6818 Q26827489-89E368BE-AF42-4E17-ABD1-DA4D945198E8 Q26995779-8A340B6E-0EC8-4F33-A0CE-66BE999F6C2C Q27010249-3A352749-FA0C-4694-85BC-9F90E747D411 Q28080655-D3C9739F-A242-4D61-BA48-947066A49757 Q28488052-1411C9FE-6DB0-4626-8398-7FF092B0BFD5 Q28553394-F4D0BDA5-CA0E-476F-8275-908AA823F4FC Q28582616-47C07048-E24E-40D0-9675-53029DBFDE91 Q28678092-4E8DD965-E7AB-42B7-9F1B-B0B654DFD9A7 Q28833834-848E7661-F288-4361-8DCB-DD38FEA17D35 Q30276331-18BA1E1F-1AAB-4894-A3D2-45EFD87F7DA9 Q30449041-80DEC29F-EC47-431F-ACEE-56EC323C7008 Q30486735-F01910A5-55F2-4C45-805B-5A97511A3F40 Q30489239-63EB4D29-789E-4DF7-B44D-CBF73FA8A4A5 Q30498803-0E6C4B86-AEFC-4B84-9362-3A676429A904 Q30540814-FC0FB542-FC96-4958-86B3-5D5A21DBCF01 Q33654786-C4367300-AE52-48AA-87C3-210B101BE4E2 Q33717822-DA980079-7D46-45EA-A3E5-4AD97048DDDF Q33780658-D947062B-F931-4A54-9DA8-B63F6B837EB1 Q33801747-A60B9F7D-3358-4F1B-BB9E-2C395973E826 Q33841023-82F3B431-4EAE-4E61-88DF-07B0399F613A Q34073523-466F21F8-5A3C-4270-85EA-4FFE8154F13F Q34101834-4A78B6E0-A24B-42D6-91D2-55F32E78DFF1 Q34125233-A72FAE62-8A76-4A3A-8D5E-1D65C5A80134 Q34278261-14626A46-578D-4D16-818E-994559DA6CA3 Q34319661-9C5A865D-E861-48FE-BBA1-83CD0E2D55CB Q34430758-945B5A59-9DF0-426B-9EC8-32E9BE6460D4 Q34451073-DA816BC7-59B7-441B-9431-A3CE95A0EC97 Q34613758-79E1CE86-CB17-42DD-B474-7E6964333A58 Q34707072-1898C809-A543-451B-98C5-735F328CB2EB Q34946861-A356BEFE-3024-4F78-BDF2-3503D6192623 Q35055551-788B9E60-9F88-49B4-B77C-ABA1A3A91C92 Q35111345-57B075D7-CE19-4FA4-BE0D-C36C7A8AF387 Q35304761-CE04CB27-CD7D-4E04-84DC-FB728A565F2C Q35395940-77D30A51-C139-4C9C-A8FB-E61CFBD5B2E4

P2860

International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels

http://www.wikidata.org/entity/Q28289168

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

International Union of Pharmac ...... m-activated potassium channels

@ast

International Union of Pharmac ...... m-activated potassium channels

@en

International Union of Pharmac ...... m-activated potassium channels

@nl

type

label

International Union of Pharmac ...... m-activated potassium channels

@ast

International Union of Pharmac ...... m-activated potassium channels

@en

International Union of Pharmac ...... m-activated potassium channels

@nl

prefLabel

International Union of Pharmac ...... m-activated potassium channels

@ast

International Union of Pharmac ...... m-activated potassium channels

@en

International Union of Pharmac ...... m-activated potassium channels

@nl

P1433

Q28289168-57980408-A185-45BF-B2D5-2197EB812D58

P1476

Q28289168-4D394ED1-BB1A-42F4-AF32-459D81ABE23F

P2093

Q28289168-3AA4A973-4E31-4CB1-B10B-E5B19842150A

Q28289168-3AD7391A-AB08-4FF1-96B4-04ED33A595E0

Q28289168-6CEC5CC6-5F8D-4DD2-9286-CBB9F4BF3E20

Q28289168-81B0285A-0D29-4EEF-9719-2A2FDA90CF5A

Q28289168-BE1628CD-FB16-424D-8D39-3446663AB837

Q28289168-C165B7B2-6D7A-4A91-AE9C-BAFFA30939DA

P304

Q28289168-AE0F9463-F1FF-48AC-8BCB-D880CD95DE4D

P31

Q28289168-27AC4947-836E-459B-8F3D-D3ECA0C87A42

P3181

Q28289168-8A5AF792-711B-43D3-92E2-230D4AB3324B

P356

Q28289168-158F5D27-9DC4-45D3-88F5-E6D560BC48E8

P407

Q28289168-F202F18D-76A8-4E19-8AB7-070200B5A879

P433

Q28289168-2BDD86FA-FE43-4324-8DB2-4BB0052D130E

P478

Q28289168-78FFCC8A-D984-4D76-BDC3-7DE9F0A37092

P577

Q28289168-6074E2A2-98CB-44D6-9649-EBCE63EC5015

P5875

Q28289168-4A165429-4A50-4C8E-B632-C9AB663DF7BF

P698

Q28289168-E44BF3FB-BF5D-4CA3-8F6E-98A98C3CBA17

P921

Q28289168-D314D831-4357-4434-9F4E-CEF9A3B4F0E9

P3181

P356

P1433

Pharmacological Reviews

P1476

International Union of Pharmac ...... m-activated potassium channels

@en

P2093

Aguan D Wei

http://www.w3.org/2001/XMLSchema#string

George A Gutman

http://www.w3.org/2001/XMLSchema#string

Heike Wulff

http://www.w3.org/2001/XMLSchema#string

K George Chandy

http://www.w3.org/2001/XMLSchema#string

Richard Aldrich

http://www.w3.org/2001/XMLSchema#string

Stephan Grissmer

http://www.w3.org/2001/XMLSchema#string

P304

463-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2022240

http://www.w3.org/2001/XMLSchema#string

P356

10.1124/PR.57.4.9

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7389541

http://www.w3.org/2001/XMLSchema#string

P698

16382103

http://www.w3.org/2001/XMLSchema#string

P921